ES2530457T3 - Secuencias peptídicas, su forma ramificada y uso de estas para aplicaciones antimicrobianas - Google Patents

Secuencias peptídicas, su forma ramificada y uso de estas para aplicaciones antimicrobianas Download PDF

Info

Publication number
ES2530457T3
ES2530457T3 ES09737145T ES09737145T ES2530457T3 ES 2530457 T3 ES2530457 T3 ES 2530457T3 ES 09737145 T ES09737145 T ES 09737145T ES 09737145 T ES09737145 T ES 09737145T ES 2530457 T3 ES2530457 T3 ES 2530457T3
Authority
ES
Spain
Prior art keywords
peptide sequences
branched form
antimicrobial applications
ident
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09737145T
Other languages
English (en)
Inventor
Luisa Bracci
Chiara Falciani
Alessandro Pini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita degli Studi di Siena
Original Assignee
Universita degli Studi di Siena
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universita degli Studi di Siena filed Critical Universita degli Studi di Siena
Application granted granted Critical
Publication of ES2530457T3 publication Critical patent/ES2530457T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Un péptido antibacteriano que tiene del terminal amino al carboxílico una secuencia de aminoácidos seleccionada del grupo de: KKIRVRLSA, sec. con núm. de ident. 1, RRIRVRLSA, sec. con núm. de ident. 2, KRIRVRLSA, sec. con núm. de ident. 3, RKIRVRLSA, sec. con núm. de ident. 4.
ES09737145T 2008-10-05 2009-10-05 Secuencias peptídicas, su forma ramificada y uso de estas para aplicaciones antimicrobianas Active ES2530457T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10285408P 2008-10-05 2008-10-05
PCT/IB2009/054347 WO2010038220A1 (en) 2008-10-05 2009-10-05 Peptide sequences, their branched form and use thereof for antimicrobial applications

Publications (1)

Publication Number Publication Date
ES2530457T3 true ES2530457T3 (es) 2015-03-03

Family

ID=41723005

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09737145T Active ES2530457T3 (es) 2008-10-05 2009-10-05 Secuencias peptídicas, su forma ramificada y uso de estas para aplicaciones antimicrobianas

Country Status (10)

Country Link
US (1) US8440794B2 (es)
EP (1) EP2344178B1 (es)
JP (1) JP5773271B2 (es)
CN (1) CN102170899A (es)
DK (1) DK2344178T3 (es)
ES (1) ES2530457T3 (es)
PL (1) PL2344178T3 (es)
PT (1) PT2344178E (es)
SI (1) SI2344178T1 (es)
WO (1) WO2010038220A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2409579A1 (en) 2010-07-23 2012-01-25 Setlance S.r.L. Antimicrobial peptide, branched forms and uses thereof for the cure of bacteria infections
ITRM20130565A1 (it) * 2013-10-14 2015-04-15 Univ Siena Composti anti tnf-alpha e loro usi
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria
EP3354274A1 (en) 2017-01-25 2018-08-01 SETLANCE S.r.l. Therapeutic combinations for the treatment of bacterial infections
EP3392265A1 (en) 2017-04-20 2018-10-24 SETLANCE S.r.l. Methods for removing bacterial toxins from a biological fluid
CN108196073B (zh) * 2018-03-13 2019-09-13 江苏浩欧博生物医药股份有限公司 一种测定抗环瓜氨酸肽抗体的试剂盒及其应用
US10413584B1 (en) * 2018-08-29 2019-09-17 Riptide Bioscience, Inc. Peptides having immunomodulatory properties
US10548944B1 (en) 2018-10-19 2020-02-04 Riptide Bioscience, Inc. Antimicrobial peptides and methods of using the same
WO2020175936A1 (ko) * 2019-02-28 2020-09-03 단디바이오사이언스 주식회사 항균활성을 갖는 폴리펩타이드, 이를 포함하는 패혈증 예방 또는 치료용 조성물, 및 항균용 조성물
JP2022527133A (ja) 2019-04-12 2022-05-30 リップタイド バイオサイエンス インコーポレイテッド マクロファージの活性を調節する方法
KR102215798B1 (ko) * 2019-10-31 2021-02-15 이수경 항균 펩타이드를 포함하는 보존제 및 이를 이용한 화장료 조성물
CN114805495B (zh) * 2022-06-15 2023-07-07 东北农业大学 一种抗酶解分枝状抗菌肽Pal-CRKP及其制备方法和应用
IT202200025365A1 (it) 2022-12-12 2024-06-12 Medica S P A Procedimento di realizzazione di un dispositivo e dispositivo per il trattamento di fluidi
EP4665372A1 (en) 2023-02-13 2025-12-24 EnliTISA (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides
WO2024260465A1 (en) 2023-06-22 2024-12-26 Enlitisa (Shanghai) Pharmaceutical Co., Ltd. New multi-functional oligopeptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20040349A1 (it) * 2004-07-13 2004-10-13 Univ Siena Peptidi antibatterici e loro analoghi.
WO2009146885A2 (en) * 2008-06-02 2009-12-10 Spiderbiotech S.R.L. Lipidated antibacterial peptides

Also Published As

Publication number Publication date
WO2010038220A1 (en) 2010-04-08
EP2344178A1 (en) 2011-07-20
SI2344178T1 (sl) 2015-04-30
JP2012504597A (ja) 2012-02-23
EP2344178B1 (en) 2014-12-03
CN102170899A (zh) 2011-08-31
PL2344178T3 (pl) 2015-05-29
DK2344178T3 (en) 2015-02-16
JP5773271B2 (ja) 2015-09-02
US20110190198A1 (en) 2011-08-04
PT2344178E (pt) 2015-02-18
US8440794B2 (en) 2013-05-14

Similar Documents

Publication Publication Date Title
ES2530457T3 (es) Secuencias peptídicas, su forma ramificada y uso de estas para aplicaciones antimicrobianas
ES2528133T3 (es) Péptidos y composiciones para prevención de la adhesión celular, y métodos para utilizar los mismos
UA118167C2 (uk) Пептид та його застосування
CO6700829A2 (es) Moduladores novedosos y métodos de uso
EA201100084A1 (ru) Сшиваемая полимерная композиция
BR112012014082A2 (pt) composições e métodos que compreendem variantes de protease
EA201000327A1 (ru) Белок
ES2691070T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
MX2019013387A (es) Dominio de union a antigeno.
ES2693321T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
MX386437B (es) Anticuerpos anti-fap y métodos de utilización.
CO6450665A2 (es) Anticuerpos anti-fgfr3 y métodos que los utilizan
NI201600028A (es) Polipéptido para la escisión hidrolítica de la zearalenona y/o derivados de la zearalenona, polinucleótido aislado de la misma y poliéptido que contiene aditivo, uso y procedimiento de los mismos.
MX392683B (es) Composiciones farmaceuticas que comprenden variantes peptidicos y metodos para su uso.
PE20160045A1 (es) Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados
CL2016000344A1 (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
ES2545457T3 (es) Vacunas de péptidos para cánceres que expresan los polipéptidos DEPDC1
CL2013003145A1 (es) Formulación farmacéutica que comprende mezcla de anticuerpo anti-alfa4beta7, un antioxidante o quelante y al menos un aminoácido libre.
BRPI1015043A2 (pt) derivados de diazahomoadamantano e métodos de uso dos mesmos
JOP20200323A1 (ar) طرق لتصنيع تركيبات الأحماض الأمينية
AR120721A2 (es) Péptidos y composiciones para el tratamiento de daño articular
AR067980A1 (es) Peptidos de cdh3 y agentes que los comprenden
AR100768A1 (es) Método para disminuir la inmunogenicidad de proteínas y péptidos
BR112014028130A2 (pt) Sal de cloridrato de um peptídeo, composição farmacêutica, uso de um sal de cloridrato, uso de uma composição farmacêutica, e, método para evitar ou tratar alergia a gatos
EP4269562A3 (en) Antigen binding molecules and methods of use thereof